BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 28434661)

  • 1. Retrospective Review of Percutaneous Image-Guided Ablation of Oligometastatic Prostate Cancer: A Single-Institution Experience.
    Erie AJ; Morris JM; Welch BT; Kurup AN; Weisbrod AJ; Atwell TD; Schmit GD; Kwon ED; Callstrom MR
    J Vasc Interv Radiol; 2017 Jul; 28(7):987-992. PubMed ID: 28434661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single-institution experience in image-guided thermal ablation of adrenal gland metastases.
    Welch BT; Callstrom MR; Carpenter PC; Wass CT; Welch TL; Boorjian SA; Nichols DA; Thompson GB; Lohse CM; Erickson D; Leibovich BC; Atwell TD
    J Vasc Interv Radiol; 2014 Apr; 25(4):593-8. PubMed ID: 24507995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits of Using Stereotactic Body Radiotherapy in Patients With Metachronous Oligometastases of Hormone-Sensitive Prostate Cancer Detected by [18F]fluoromethylcholine PET/CT.
    Bouman-Wammes EW; van Dodewaard-De Jong JM; Dahele M; Cysouw MCF; Hoekstra OS; van Moorselaar RJA; Piet MAH; Verberne HJ; Bins AD; Verheul HMW; Slotman BJ; Oprea-Lager DE; Van den Eertwegh AJM
    Clin Genitourin Cancer; 2017 Oct; 15(5):e773-e782. PubMed ID: 28462855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission.
    McMenomy BP; Kurup AN; Johnson GB; Carter RE; McWilliams RR; Markovic SN; Atwell TD; Schmit GD; Morris JM; Woodrum DA; Weisbrod AJ; Rose PS; Callstrom MR
    J Vasc Interv Radiol; 2013 Feb; 24(2):207-13. PubMed ID: 23265724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recurrence and Survival Outcomes After Percutaneous Thermal Ablation of Oligometastatic Melanoma.
    White ML; Atwell TD; Kurup AN; Schmit GD; Carter RE; Geske JR; Kottschade LA; Pulido JS; Block MS; Jakub JW; Callstrom MR; Markovic SN
    Mayo Clin Proc; 2016 Mar; 91(3):288-96. PubMed ID: 26827235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II randomized trial of Observation versus stereotactic ablative RadiatIon for OLigometastatic prostate CancEr (ORIOLE).
    Radwan N; Phillips R; Ross A; Rowe SP; Gorin MA; Antonarakis ES; Deville C; Greco S; Denmeade S; Paller C; Song DY; Diehn M; Wang H; Carducci M; Pienta KJ; Pomper MG; DeWeese TL; Dicker A; Eisenberger M; Tran PT
    BMC Cancer; 2017 Jun; 17(1):453. PubMed ID: 28662647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiographic Local Tumor Control and Pain Palliation of Sarcoma Metastases within the Musculoskeletal System with Percutaneous Thermal Ablation.
    Vaswani D; Wallace AN; Eiswirth PS; Madaelil TP; Chang RO; Tomasian A; Jennings JW
    Cardiovasc Intervent Radiol; 2018 Aug; 41(8):1223-1232. PubMed ID: 29541840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 68Ga-PSMA-PET/CT-based radiosurgery and stereotactic body radiotherapy for oligometastatic prostate cancer.
    Kalinauskaite G; Senger C; Kluge A; Furth C; Kufeld M; Tinhofer I; Budach V; Beck M; Hochreiter A; Grün A; Stromberger C
    PLoS One; 2020; 15(10):e0240892. PubMed ID: 33085712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligometastases from prostate cancer: local treatment with stereotactic body radiotherapy (SBRT).
    Habl G; Straube C; Schiller K; Duma MN; Oechsner M; Kessel KA; Eiber M; Schwaiger M; Kübler H; Gschwend JE; Combs SE
    BMC Cancer; 2017 May; 17(1):361. PubMed ID: 28532400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Over ten years of single-institution experience in percutaneous image-guided treatment of bone metastases from differentiated thyroid cancer.
    Cazzato RL; Bonichon F; Buy X; Godbert Y; de Figuereido BH; Pointillart V; Palussière J
    Eur J Surg Oncol; 2015 Sep; 41(9):1247-55. PubMed ID: 26136221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oligometastatic adrenocortical carcinoma: the role of image-guided thermal ablation.
    Veltri A; Basile D; Calandri M; Bertaggia C; Volante M; Porpiglia F; Calabrese A; Puglisi S; Basile V; Terzolo M
    Eur Radiol; 2020 Dec; 30(12):6958-6964. PubMed ID: 32621242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and feasibility of image-guided robotic radiosurgery for patients with limited bone metastases of prostate cancer.
    Muacevic A; Kufeld M; Rist C; Wowra B; Stief C; Staehler M
    Urol Oncol; 2013 May; 31(4):455-60. PubMed ID: 21481619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous image-guided ablation of bone metastases: local tumor control in oligometastatic patients.
    Luigi Cazzato R; Auloge P; De Marini P; Rousseau C; Chiang JB; Koch G; Caudrelier J; Rao P; Garnon J; Gangi A
    Int J Hyperthermia; 2018; 35(1):493-499. PubMed ID: 30307346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small liver colorectal metastases treated with percutaneous radiofrequency ablation: local response rate and long-term survival with up to 10-year follow-up.
    Solbiati L; Ahmed M; Cova L; Ierace T; Brioschi M; Goldberg SN
    Radiology; 2012 Dec; 265(3):958-68. PubMed ID: 23091175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary non-small cell lung cancer: review of frequency, location, and time of recurrence after radiofrequency ablation.
    Beland MD; Wasser EJ; Mayo-Smith WW; Dupuy DE
    Radiology; 2010 Jan; 254(1):301-7. PubMed ID: 20032160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local Control and Survival after Image-Guided Percutaneous Ablation of Adrenal Metastases.
    Frenk NE; Daye D; Tuncali K; Arellano RS; Shyn PB; Silverman SG; Fintelmann FJ; Uppot RN
    J Vasc Interv Radiol; 2018 Feb; 29(2):276-284. PubMed ID: 28927661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Avoidance of androgen deprivation therapy in radiorecurrent prostate cancer as a clinically meaningful endpoint for salvage cryoablation.
    Ginsburg KB; Elshafei A; Yu C; Jones JS; Cher ML
    Prostate; 2017 Oct; 77(14):1446-1450. PubMed ID: 28856702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and oncologic control after percutaneous image guided ablation of metastatic renal cell carcinoma.
    Welch BT; Callstrom MR; Morris JM; Kurup AN; Schmit GD; Weisbrod AJ; Lohse CM; Kohli M; Costello BA; Olivier KR; Thompson RH; Boorjian SA; Atwell TD
    J Urol; 2014 Aug; 192(2):357-63. PubMed ID: 24631107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cryoablation of Bone Metastases from Renal Cell Carcinoma for Local Tumor Control.
    Gardner CS; Ensor JE; Ahrar K; Huang SY; Sabir SH; Tannir NM; Lewis VO; Tam AL
    J Bone Joint Surg Am; 2017 Nov; 99(22):1916-1926. PubMed ID: 29135665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes.
    Overduin CG; Jenniskens SFM; Sedelaar JPM; Bomers JGR; Fütterer JJ
    Eur Radiol; 2017 Nov; 27(11):4828-4836. PubMed ID: 28409355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.